Jan Wesström1, Alkistis Skalkidou2, Mauro Manconi3, Stephany Fulda3, Inger Sundström-Poromaa2. 1. Department of Women's and Children's Health, Uppsala University, Uppsala, Sweden ; Center for Clinical Research Dalarna, Falun, Sweden. 2. Department of Women's and Children's Health, Uppsala University, Uppsala, Sweden. 3. Sleep and Epilepsy Centre, Neurocenter (EOC) of Southern Switzerland, Civic Hospital, Lugano, Switzerland.
Abstract
OBJECTIVES: Both restless legs syndrome ([RLS], also known as Willis-Ekbom Disease [WED]) and depression are common during pregnancy. However, no prior studies have assessed if pregnant women with RLS have an elevated risk of depression during and/or after pregnancy. METHODS: 1,428 women who were pregnant in gestational week 16-17 were asked to participate in a longitudinal survey. They were followed by web-based questionnaires in gestational week 17 and 32, and 6 weeks after delivery. Data were also retrieved from prenatal and birth records. Two different sets of criteria were used to examine the prevalence of RLS in the cohort (International Restless Legs Syndrome Society Group standard criteria and the later developed CH-RLSQ11 questionnaire). The latter questionnaire attempts to exclude those with common "mimics" of RLS. RESULTS: Adjusted odds ratio for depression in gestational week 17, 32, and postpartum week 6 in relation to pre-pregnancy RLS onset and moderate to severe symptom severity were 4.74 (2.30 - 9.76), 3.67 (1.85 - 7.28), and 2.58 (1.28 - 5.21), respectively. No significant associations were seen in pregnant women with de novo RLS during pregnancy. When using the standard diagnostic RLS criteria and frequency of symptoms more than 2-3 days per week, the prevalence of RLS was 12.3%. With the CH-RLSQ11 questionnaire and the same threshold for frequency of symptoms the prevalence was 6.5%. CONCLUSION: Women with RLS onset before pregnancy with moderate or severe symptoms had an increased risk of both antenatal and postnatal depression. The self-reported prevalence of RLS during pregnancy is lower when a questionnaire dealing with "mimics" is used.
OBJECTIVES: Both restless legs syndrome ([RLS], also known as Willis-Ekbom Disease [WED]) and depression are common during pregnancy. However, no prior studies have assessed if pregnant women with RLS have an elevated risk of depression during and/or after pregnancy. METHODS: 1,428 women who were pregnant in gestational week 16-17 were asked to participate in a longitudinal survey. They were followed by web-based questionnaires in gestational week 17 and 32, and 6 weeks after delivery. Data were also retrieved from prenatal and birth records. Two different sets of criteria were used to examine the prevalence of RLS in the cohort (International Restless Legs Syndrome Society Group standard criteria and the later developed CH-RLSQ11 questionnaire). The latter questionnaire attempts to exclude those with common "mimics" of RLS. RESULTS: Adjusted odds ratio for depression in gestational week 17, 32, and postpartum week 6 in relation to pre-pregnancy RLS onset and moderate to severe symptom severity were 4.74 (2.30 - 9.76), 3.67 (1.85 - 7.28), and 2.58 (1.28 - 5.21), respectively. No significant associations were seen in pregnant women with de novo RLS during pregnancy. When using the standard diagnostic RLS criteria and frequency of symptoms more than 2-3 days per week, the prevalence of RLS was 12.3%. With the CH-RLSQ11 questionnaire and the same threshold for frequency of symptoms the prevalence was 6.5%. CONCLUSION:Women with RLS onset before pregnancy with moderate or severe symptoms had an increased risk of both antenatal and postnatal depression. The self-reported prevalence of RLS during pregnancy is lower when a questionnaire dealing with "mimics" is used.
Entities:
Keywords:
depression; pregnancy; restless legs syndrome
Authors: Mauro Manconi; Jan Ulfberg; Klaus Berger; Imad Ghorayeb; Jan Wesström; Stephany Fulda; Richard P Allen; Thomas Pollmächer Journal: Sleep Med Rev Date: 2011-11-09 Impact factor: 11.609
Authors: Christine Rubertsson; Karin Börjesson; Anna Berglund; Ann Josefsson; Gunilla Sydsjö Journal: Nord J Psychiatry Date: 2011-07-05 Impact factor: 2.202
Authors: R Gupta; M Dhyani; T Kendzerska; S R Pandi-Perumal; A S BaHammam; P Srivanitchapoom; S Pandey; M Hallett Journal: Acta Neurol Scand Date: 2015-10-19 Impact factor: 3.209
Authors: Virginia A Aparicio; Olga Ocón; Carmen Padilla-Vinuesa; Alberto Soriano-Maldonado; Lidia Romero-Gallardo; Milkana Borges-Cósic; Irene Coll-Risco; Pilar Ruiz-Cabello; Pedro Acosta-Manzano; Fernando Estévez-López; Inmaculada C Álvarez-Gallardo; Manuel Delgado-Fernández; Jonatan R Ruiz; Mireille N Van Poppel; Julio J Ochoa-Herrera Journal: BMC Pregnancy Childbirth Date: 2016-09-29 Impact factor: 3.007